Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact
Myriad Genetics (MYGN) MRD test is uniquely capable of detecting ctDNA at the lowest levels of detection, which is essential…
7,637$
0,49%
Echtzeit-Aktienkurs Myriad Genetics Inc.
Bid:
Ask:
Nachrichten zur Myriad Genetics Inc. Aktie
Myriad Genetics target raised to $28 on firm outlook By Investing.com
Myriad Genetics target raised to $28 on firm outlook…
Earnings call: Myriad Genetics reports positive 2023 results, eyes growth By Investing.com
Earnings call: Myriad Genetics reports positive 2023 results, eyes growth…
Myriad Genetics, Inc. (MYGN) Q4 2023 Earnings Call Transcript
…
Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down
Myriad Genetics (MYGN) registers a strong testing volume improvement across all its businesses in the fourth quarter of 2023.…
Myriad Genetics, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
Myriad’s Precise MRD test will be used to evaluate the broad applicability of MRD testing across many cancer types Myriad’s…